| __timestamp | Bio-Techne Corporation | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 106352000 | 179279000 |
| Thursday, January 1, 2015 | 144969000 | 186359000 |
| Friday, January 1, 2016 | 162364000 | 171785000 |
| Sunday, January 1, 2017 | 188462000 | 208136000 |
| Monday, January 1, 2018 | 210850000 | 198405000 |
| Tuesday, January 1, 2019 | 240515000 | 224169000 |
| Wednesday, January 1, 2020 | 255497000 | 245044000 |
| Friday, January 1, 2021 | 298182000 | 252314000 |
| Saturday, January 1, 2022 | 349103000 | 268225000 |
| Sunday, January 1, 2023 | 366887000 | 304629000 |
| Monday, January 1, 2024 | 389335000 | 324203000 |
Data in motion
In the ever-evolving landscape of the bio-pharmaceutical industry, understanding cost dynamics is crucial. This analysis focuses on the cost of revenue trends for Bio-Techne Corporation and Taro Pharmaceutical Industries Ltd. over the past decade. From 2014 to 2024, Bio-Techne Corporation's cost of revenue surged by approximately 266%, reflecting its strategic investments and expansion. Meanwhile, Taro Pharmaceutical Industries Ltd. experienced a 81% increase, indicating steady growth.
These trends underscore the companies' commitment to innovation and market expansion, positioning them as key players in the bio-pharmaceutical sector.
Cost of Revenue Comparison: AstraZeneca PLC vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Pfizer Inc. and Taro Pharmaceutical Industries Ltd.'s Expenses
Neurocrine Biosciences, Inc. vs Bio-Techne Corporation: Efficiency in Cost of Revenue Explored
Bio-Techne Corporation vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Bio-Techne Corporation vs Perrigo Company plc
Analyzing Cost of Revenue: Bio-Techne Corporation and MiMedx Group, Inc.
Bio-Techne Corporation vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
Who Optimizes SG&A Costs Better? Bio-Techne Corporation or Taro Pharmaceutical Industries Ltd.
Xenon Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Dyne Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Celldex Therapeutics, Inc.